Tympanic Membrane Perforation Clinical Trial
Official title:
Evaluation of Prognostic Factors and Middle Ear Risk Index in Tympanoplasty
Verified date | January 2018 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Tympanoplasty is the surgical operation performed for the reconstruction of the eardrum
and/or the ossicles. Tympanoplasty is classified into five different types, originally
described by Horst Ludwig Wullstein. 1,2 Type 1 involves repair of the tympanic membrane
alone, when the middle ear is normal. A type 1 tympanoplasty is synonymous to myringoplasty,
Type 2 involves repair of the tympanic membrane and middle ear in spite of slight defects in
the middle ear ossicles, Type 3 when mallus and incus are absent graft place directly on
stapes head., Type 4 describes a repair when the stapes foot plate is movable, but the crura
are missing. The resulting middle ear will only consist of the Eustachian tube and
hypotympanum, Type 5 is a repair involving a fixed stapes footplate.
There are various prognostic factors reported in the literature that may influence the
surgical success of tympanoplasty.
Status | Not yet recruiting |
Enrollment | 70 |
Est. completion date | March 1, 2020 |
Est. primary completion date | March 1, 2019 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - patients of the age group 18-60 years with Chronic suppurative otitis media (CSOM) planned for tympanoplasty. Exclusion Criteria: - Patients with otomycosis, septic foci such as sinusitis which can influence the outcome of tympanoplasty were excluded from the study |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Becvarovski Z, Kartush JM. Smoking and tympanoplasty: implications for prognosis and the Middle Ear Risk Index (MERI). Laryngoscope. 2001 Oct;111(10):1806-11. — View Citation
Kartush JM. Ossicular chain reconstruction. Capitulum to malleus. Otolaryngol Clin North Am. 1994 Aug;27(4):689-715. Review. — View Citation
WULLSTEIN H. Theory and practice of tympanoplasty. Laryngoscope. 1956 Aug;66(8):1076-93. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of prognostic factors in tympanoplasty to predict the outcome of the surgical management whenever done. | Prognostic factors such as age, sex, presence of systemic diseases, location and size of perforation, duration of dry period, presence of myringosclerosis, presence of septal and conchal pathology and status of the opposite ear and middle ear risk index will be investigated. | One year | |
Primary | Evaluation of middle ear risk index in tympanoplasty | Each risk parameter will take a numerical value; Ear discharge: 0-3, Perforation: 0-2, Cholesteotoma: 0-2, Ossicular chain status: 0-4, Middle ear granulation and history of previous surgery: 0-2. Now newly, smoking is also included as a risk parameter. The MERI will be evaluated. The patients will be categorized into those with mild (0-3), moderate(4-6) and severe(=7) MERI | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635228 -
Biodesign® Otologic Repair Graft
|
||
Active, not recruiting |
NCT00222417 -
Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05086718 -
Composite Cartilage Perichondrium Graft for Air Bone Gap Closure in Chronic Suppurative Otitis Media (CSOM) Without Posterior Meatal Flap
|
N/A | |
Withdrawn |
NCT03904316 -
Use of Biodesign® Otologic Graft in Tympanoplasty
|
Phase 4 | |
Completed |
NCT02307916 -
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
|
Phase 2 | |
Terminated |
NCT01766856 -
Eustachian Tube Function and Myringoplasty/Tympanoplasty
|
N/A | |
Recruiting |
NCT06260618 -
Effect of Chitodex Gel in Tympanoplasty Surgery
|
N/A | |
Recruiting |
NCT04960384 -
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
|
Phase 2 | |
Recruiting |
NCT03837665 -
Efficacy of Platelet Enriched Plasma in Preventing Surgery for Patients With Chronic Tympanic Membrane Perforation
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06257602 -
Microscopic Versus Endoscopic Tympanoplasty
|
||
Completed |
NCT02550314 -
A Study on the Regenerative Treatment of Tympanic Membrane With NPC-18 and FBG-18
|
Phase 3 | |
Not yet recruiting |
NCT00310349 -
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease
|
Phase 3 | |
Not yet recruiting |
NCT04428463 -
Repair of Tympanic Membrane Perforation Using Tachosil Under Local Anesthesia
|
N/A | |
Completed |
NCT00714064 -
PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers
|
Phase 3 | |
Completed |
NCT05605262 -
Effects of 100% Medical Grade Manuka Honey on Tympanic Membrane Reconstruction Healing.
|
Phase 2/Phase 3 | |
Completed |
NCT02296944 -
Anatomical and Functional Results of Surgery of the Tympanic Membrane Perforation of the Child
|
N/A | |
Recruiting |
NCT05849844 -
Tympanoseal Clinical Study
|
N/A | |
Not yet recruiting |
NCT04687995 -
Tragal Perichondrium Versus Pretragal Fascial (SMAS) Graft for Endoscopic Myringoplasty
|
N/A | |
Completed |
NCT02120651 -
Fibrin Monomer Compared With Hemostatic Sponge in the Integrity of the Graft During Tympanoplasty
|
Phase 3 | |
Withdrawn |
NCT03028272 -
Hearing Results and Post Surgical Outcomes Using Amniotic Membrane Allograft vs. Fascia for Tympanoplasty
|
N/A |